JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB178690

Anti-TAF1C antibody [EPR11298]

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal TAF1C antibody. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication.

View Alternative Names

TATA box-binding protein-associated factor RNA polymerase I subunit C, RNA polymerase I-specific TBP-associated factor 110 kDa, TATA box-binding protein-associated factor 1C, Transcription initiation factor SL1/TIF-IB subunit C, TAFI110, TBP-associated factor 1C, TAF1C

2 Images
Immunoprecipitation - Anti-TAF1C antibody [EPR11298] (AB178690)
  • IP

Supplier Data

Immunoprecipitation - Anti-TAF1C antibody [EPR11298] (AB178690)

Western blot analysis on immunoprecipitation pellet from 293T cell lysate using ab178690.

All lanes:

Immunoprecipitation - Anti-TAF1C antibody [EPR11298] (ab178690)

Predicted band size: 95 kDa

Observed band size: 95 kDa

false

Western blot - Anti-TAF1C antibody [EPR11298] (AB178690)
  • WB

Supplier Data

Western blot - Anti-TAF1C antibody [EPR11298] (AB178690)

All lanes:

Western blot - Anti-TAF1C antibody [EPR11298] (ab178690) at 1/1000 dilution

Lane 1:

HeLa cell lysate at 10 µg

Lane 2:

Jurkat cell lysate at 10 µg

Lane 3:

293T cell lysate at 10 µg

Predicted band size: 95 kDa

false

  • Carrier free

    Anti-TAF1C antibody [EPR11298] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR11298

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Complementary Products

Primary Antibodies

AB192238

Anti-SRPK2 antibody [EPR16366] - N-terminal

RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SRPK2 antibody [EPR16366] - N-terminal (AB192238)

  • 0
  • 0
Primary Antibodies

AB251223

Anti-POLR1C antibody [EPR16178] - BSA and Azide free

RabMAb|Recombinant

Western blot - Anti-POLR1C antibody [EPR16178] - BSA and Azide free (AB251223)

  • 0
  • 0
Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Primary Antibodies

AB181152

Anti-ZCCHC8 antibody [EPR13612]

RabMAb|Recombinant|Trial Size

Immunocytochemistry/ Immunofluorescence - Anti-ZCCHC8 antibody [EPR13612] (AB181152)

  • 0
  • 0
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }
style
left-column

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TAF1C also known as Transcription Initiation Factor TFIID Subunit 1C is a component of the transcription factor complex that plays an important role in the initiation of transcription by RNA polymerase I. It has a molecular mass of approximately 64 kDa. TAF1C is mainly expressed in the nucleolus of eukaryotic cells where it aids in forming the transcription preinitiation complex. The protein interacts specifically with other subunits to enable the RNA polymerase I to initiate the transcription of ribosomal RNA genes.
Biological function summary

TAF1C is essential for assembling the RNA polymerase I complex often referred to as the SL1 complex. This complex includes other components like TBP and several TAFs which together promote the transcription of rRNA genes critical for ribosome biogenesis. By participating in the formation of this complex TAF1C impacts cellular growth by influencing ribosome production. The functional activity of TAF1C thereby strongly ties to cellular metabolism given its position in rRNA transcription machinery.

Pathways

TAF1C is involved in the rRNA synthesis pathway a pathway important for ribosome production. This pathway interfaces with the cell growth and division pathways with proteins like TBP and other transcription factors forming significant parts of these linked networks. TAF1C contributes to maintaining cellular homeostasis by its functions in these pathways impacting how cells respond and adapt to metabolic demands and growth signals.

TAF1C has connections to diseases like cancer due to its involvement in ribosome biogenesis. Altered expression of TAF1C affects nucleolar activity which is often observed in tumor cells. Moreover any disruption in its function can lead to dysregulation of rRNA synthesis linking it indirectly to p53 a protein involved in cell cycle regulation and apoptosis. Aberrant regulation or mutations in TAF1C-related pathways may fuel disease progression and are subjects of current research interest in oncology.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (pre-initiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1/TIF-IB with the rDNA promoter. SL1/TIF-IB is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA. Formation of SL1/TIF-IB excludes the association of TBP with TFIID subunits. Recruits RNA polymerase I to the rRNA gene promoter via interaction with RRN3.
See full target information TATA box-binding protein-associated factor RNA polymerase I subunit C
style
left-column

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Life science alliance 6: PubMed36316035

2022

CRISPRi screening reveals regulators of tau pathology shared between exosomal and vesicle-free tau.

Applications

Unspecified application

Species

Unspecified reactive species

Juan Carlos Polanco,Yevhen Akimov,Avinash Fernandes,Adam Briner,Gabriel Rhys Hand,Marloes van Roijen,Giuseppe Balistreri,Jürgen Götz
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com